Newspaper Publication for the financial results for the quarter and nine months ended 31st December, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kimia Biosciences Ltd has submitted copies of newspaper advertisements published on February 15, 2026 in Financial Express (English) and Jansatta (Hindi), as required under SEBI Listing Regulations, containing its unaudited standalone financial results for the quarter and nine months ended December 31, 2025. For Q3 FY26 (standalone), revenue from operations stood at Rs 3,010.06 lakh, down from Rs 3,399.93 lakh in the previous quarter but almost flat versus Rs 3,009.91 lakh in Q3 FY25. Net profit surged to Rs 544.15 lakh from Rs 101.51 lakh in Q2 FY26, with EPS rising to Rs 1.15 from Rs 0.21. For the nine-month period, revenue fell to Rs 6,768.40 lakh from Rs 8,057.70 lakh a year earlier, while net profit slipped marginally to Rs 706.06 lakh from Rs 762.07 lakh, with EPS at Rs 1.49 versus Rs 1.61.
The sharp sequential jump in quarterly profit is a positive signal, but the year-on-year decline in both nine-month revenue and profit suggests underlying business pressure. Shareholders should watch for margin trends and any commentary from management on the revenue slowdown.